Marcus Lind presented his thesis in year 2009 at the University of Gothenburg focusing on evaluating effects of modern insulin analogues and HbA1c as a risk factor for diabetic complications. During his post-doc period he performed work at the Mid-America Heart Institute, Missouri University, US.
Besides his research he has worked clinical as chief physician of Diabetology at the NU (NÄL and Uddevalla)-Hospital Group. He became Associate Professor of Diabetology year 2014 at the University of Gothenburg. He has performed essential research both in the epidemiologic field and clinical randomized trials which have been presented in New England Journal of Medicine, Lancet, JAMA and British Medical Journal. He has been in charge of over 40 studies.
Honors and Awards:
Main research
Dr Marcus Lind focuses on clinical diabetes research. His research performs epidemiologic studies and clinical trials in the field of diabetes.
The research is focused on improving prognosis and evaluating suitable treatments to reduce the risk of complications for type 1 and 2 diabetes.
Dr Lind performs research evaluating which risk factors are associated with a lower mortality and risks of complications on the retina, kidneys, nerves and cardiovascular system. His group also focuses on understanding what persons are at risk for acute complications from diabetes. These studies are often of epidemiologic origin. As a complement the research group perform prospective studies and clinical trials to try to improve treatments in type 1 and type 2 diabetes. Essential fields are:
- Screening studies to earlier detect complications
- Diabetes Technology – e.g. of continuous glucose monitoring and insulin pumps
- Psychologic interventions
- Diet interventions
- Glucose-lowering drugs in persons with type 1 and type 2 diabetes
Group members
Dr Lind is responsible for a Diabetes Clinical Research Unit at the Uddevalla Hospital. Which performs clinical randomized trials.
PhD Students:
- Viktorija Anägnen Matuleviciene, Chief Physician at the Emergency Department of the Karolinska University Hospital, Stockholm, Sweden
- Daniel Vestberg, Specialist Internal Medicine, NU-Hospital Group, Trollhättan and Uddevalla, Sweden
- Mauro Tancredi, Chief Physician of Endocrinology NU-Hospital Group, Trollhättan and Uddevalla, Sweden
- Elsa Ahlén, MD, Värnamo Hospital and the NU-Hospital Group, Värnamo and Uddevalla, Sweden
Research Nurses, study coordinators and junior researchers:
- Arndís Ólafsdóttir, Diabetes nurse, junior researcher, NU-Hospital Group, Trollhättan and Uddevalla, Sweden
- Sheyda Sofizadeh, Diabetes and District nurse, junior researcher, Dalaberg Primary Care Centre and NU-Hospital Group, Uddevalla Sweden
- Sofia Isaksson, Dietitian and junior researcher, NU-Hospital Group, Uddevalla, Sweden
Research assistant:
- Sofia Dahlqvist, NU-Hospital Group, Uddevalla, Sweden
Medical Doctors assisting in clinical trials:
- Bo Grände, NU-Hospital Group, Trollhättan and Uddevalla
- Thomas Eriksson, NU-Hospital Group, Trollhättan and Uddevalla
The group has built up a network of collaborations with data managers, monitors, logistics for laboratory handling, drug logistics and experienced statisticians for performing multicentre randomized clinical trials and epidemiologic studies. These are crucial close collaborators to the group for performing the research work.
Key Publications
Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J.
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
JAMA. 24;317(4):379-387. (2017)
Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M.
Excess Mortality among Persons with Type 2 Diabetes.
N Engl J Med. 373(18):1720-1732. (2015)
Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A.
Glycemic control and excess mortality in type 1 diabetes.
N Engl J Med. 371(21):1972-82. (2014)
Lind M, Hirsch IB, Tuomilehto J, Dahlqvist S, Ahrén B, Torffvit O, Attvall S, Ekelund M, Filipsson K, Tengmark BO, Sjöberg S, Pehrsson NG.
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
BMJ. 351:h5364. (2015)
Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A.
Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
Lancet. 378(9786):140-6. (2011)
Matuleviciene V, Joseph JI, Andelin M, Hirsch IB, Attvall S, Pivodic A, Dahlqvist S, Klonoff D, Haraldsson B, Lind M.
A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes.
Diabetes Technol Ther. 16(11):759-67. (2014)
Lind M, Pivodic A, Cea-Soriano L, Nerman O, Pehrsson NG, Garcia-Rodriguez LA.
Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.
Diabetologia. 57(8):1586-94. (2014)
Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Clements C, Gudbjörnsdottir S, Lind M.
Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study.
Lancet Diabetes Endocrinol. 3(11):876-85. (2015)
Ólafsdóttir A.F., Attvall S., Sandgren U., Dahlqvist S., Pivodic A., Stanko S., Theodorsson E., Lind M.
A clinical trial of the accuracy and treatment experience of the flash glucose monitor Free Style Libre in persons with type 1 diabetes.
Accepted in Diabetes Diabetes Technol Ther. 19(3):164-172. (2017)
Olsson M, Schnecke V, Cabrera C, Skrtic S, Lind M.
Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes.
Diabetes Care. 38(8):1481-6. (2015)
Facebook
Twitter
Instagram
Youtube
Weibo